Wireless neurostimulators

1. A method for treating a condition of a subject, the method comprising:

implanting an implant into a tissue of the subject, the implant shaped to define an arced portion that is shaped so as to define an outwardly-facing convex surface, and the implant including:

a circuitry unit, the circuitry unit: (a) housing circuitry, and (b) shaped to define a height, the height being smaller than (i) a longest length of the circuitry unit, measured between opposite ends of the circuitry unit, and (ii) a longest width of the circuitry unit; and

exactly two outwardly-facing electrodes that extend around the arced portion, are disposed directly on the opposite ends of the circuitry unit, and are electrically coupled to the circuitry;

wherein the step of implanting comprises orienting the implant with respect to the tissue, such that: (a) the height of the circuitry unit is disposed along a superficial-to-deep axis with respect to skin of the subject, (b) the implant is positioned to stimulate a nerve underlying the implant, and (c) the implant is positioned in a manner that inhibits electrical conduction from the exactly two outwardly-facing electrodes into skin of the subject.

2. The method according to claim 1 , wherein:

the circuitry unit is shaped to define a prismatic shape, and

the step of orienting comprises orienting the implant such that the prismatic shape of the circuitry unit is generally parallel with a plane defined by a skin surface of the subject.

3. The method according to claim 1 ,

wherein the implant includes a generally flat inhibiting element, the inhibiting element configured to inhibit electrical conduction therethrough, and

wherein orienting the implant comprises orienting the implant with respect to the tissue such that: (a) the outwardly-facing convex surface of the arced portion faces generally toward the nerve underlying the implant, and (b) the generally flat inhibiting element inhibits the electrical conduction from the exactly two outwardly-facing electrodes into the skin of the subject.

4. The method according to claim 1 , wherein:

the implant includes an inhibiting element, the inhibiting element configured to inhibit electrical conduction therethrough, and

the step of orienting comprises orienting the implant into the tissue of the subject, such that the inhibiting element inhibits electrical conduction from the exactly two outwardly-facing electrodes into tissue that is superficial to the implant.

5. The method according to claim 1 , wherein:

the height of the circuitry unit is between 0.5 and 3 mm,

the longest width of the circuitry unit is between 1 and 5 mm, and

the longest length of the circuitry unit is between 5 and 30 mm.

6. The method according to claim 1 , wherein:

the exactly two outwardly-facing electrodes are disposed at a distance of less than 10 mm from each other, and

the method further comprises, using the circuitry unit, driving current through the exactly two outwardly-facing electrodes and to the nerve.

7. The method according to claim 6 , wherein the exactly two outwardly-facing electrodes are disposed at a distance of less than 2 mm from each other.

8. The method according to claim 6 , wherein driving current comprises driving current through the exactly two outwardly-facing electrodes and to a tibial nerve of the subject to treat a condition selected from the group consisting of: neuropathic pain, and urge incontinence.

9. The method according to claim 6 , wherein the step of using the circuitry unit comprises, using a transmitting unit, transmitting a control signal that activates the circuitry unit to drive current through the exactly two outwardly-facing electrodes and to the nerve.

10. The method according to claim 1 , wherein implanting the implant comprises injecting the implant.

11. The method according to claim 1 , wherein the exactly two outwardly-facing electrodes have respective edges directly on the opposite ends the circuitry unit, and a distance between the respective edges is between 10 and 30 mm.

12. A method for treating a condition of a subject, the method comprising:

implanting an implant into a tissue of the subject, the implant shaped to define a prism that has a transverse cross-section defining an arced portion that is shaped so as to define an outwardly-facing convex surface, and the implant including:

a circuitry unit, the circuitry unit: (a) housing circuitry, and (b) shaped to define a height, the height being smaller than (i) a longest length of the circuitry unit, measured between opposite ends of the circuitry unit, and (ii) a longest width of the circuitry unit; and

exactly two outwardly-facing electrodes that face outwardly from a perimeter of the arced portion of the implant, are disposed directly on the opposite ends of the circuitry unit, and are electrically coupled to the circuitry;

wherein the step of implanting comprises orienting the implant with respect to the tissue, such that: (a) the height of the circuitry unit is disposed along a superficial-to-deep axis with respect to skin of the subject, (b) the implant is positioned to stimulate a nerve underlying the implant, and (c) the implant is positioned in a manner that inhibits electrical conduction from the exactly two outwardly-facing electrodes into skin of the subject.

13. The method according to claim 12 , wherein:

the step of implanting comprises injecting the implant into the tissue of the subject; and

the step of orienting comprises orienting the implant such that the prism is generally parallel with a plane defined by a skin surface of the subject.

14. The method according to claim 12 ,

wherein the implant includes a generally flat inhibiting element, the inhibiting element configured to inhibit electrical conduction therethrough, and

wherein orienting the implant comprises orienting the implant with respect to the tissue such that: (a) the outwardly-facing convex surface of the arced portion faces generally toward the nerve underlying the implant, and (b) the generally flat inhibiting element inhibits the electrical conduction from the exactly two outwardly-facing electrodes into the skin of the subject.

15. The method according to claim 12 , wherein:

the implant includes an inhibiting element, the inhibiting element configured to inhibit electrical conduction therethrough, and

the step of orienting comprises orienting the implant such that the inhibiting element inhibits electrical conduction from the exactly two outwardly-facing electrodes into tissue that is superficial to the implant.

16. The method according to claim 12 , wherein:

the height of the circuitry unit is between 0.5 and 3 mm,

the longest width of the circuitry unit is between 1 and 5 mm, and

the longest length of the circuitry unit is between 5 and 30 mm.

17. The method according to claim 12 , wherein:

the exactly two outwardly-facing electrodes are disposed at a distance of less than 10 mm from each other, and

the method further comprises, using the circuitry unit, driving current through the exactly two outwardly-facing electrodes and to the nerve.

18. The method according to claim 17 , wherein the exactly two outwardly-facing electrodes are disposed at a distance of less than 2 mm from each other.

19. The method according to claim 17 , wherein driving current comprises driving current through the exactly two outwardly-facing electrodes and to a tibial nerve of the subject to treat a condition selected from the group consisting of: neuropathic pain, and urge incontinence.

20. The method according to claim 17 , wherein the step of using the circuitry unit comprises, using a transmitting unit, transmitting a control signal that activates the circuitry unit to drive current through the exactly two outwardly-facing electrodes and to the nerve.

21. The method according to claim 12 , wherein the circuitry unit is shaped to define the prism that has the transverse cross-section defining the arced portion.